Tokyo, Aug. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062558) titled 'Real-World Experience and Clinical Course of Antifibrotic Therapy: A Prospective Observational Study' on Aug. 15.
Study Type:
Observational
Primary Sponsor:
Institute - Hamamatsu University School of Medicine
Condition:
Condition - fibrotic interstitial lung disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To prospectively investigate the clinical course of patients with fibrotic interstitial lung disease initiating nerandomilast in a multicenter setting.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - N...